I would say it's mostly a change in investment strategy. I can HODL these biotech assets from an average of 20 cents, but the reality is these biotech assets have definitely not bottomed and there is further downside. Would I hold something from 20 cents all the way to 4 cents? or should I sell at 12 cents and buy back in at 4 cents?
Also, a big rationale for my change in sentiment was finding more information regarding how CLTX CAR-T will perform in this indication. I've posted my findings on TransMolecular's 131-I TM-601 and how they fared in GBM in the past and with the trial completion and data updates coming in soon, that is not a risk I'm willing to take. CAR-T on solid tumours without any combination therapy to mitigate the TME is not a recipe for success.
I can change my investment thesis as I find more information. If the data is good and proves me wrong, I would buy back in. If this is undervalued, a 2x in the price would only bring this stock to an 80M market cap and that is still undervalued.
- Forums
- ASX - By Stock
- Charting Only
I would say it's mostly a change in investment strategy. I can...
-
-
- There are more pages in this discussion • 340 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.18M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 2044476 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 328619 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 2044476 | 0.016 |
19 | 2586784 | 0.015 |
3 | 708475 | 0.014 |
3 | 422223 | 0.013 |
2 | 83412 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 328619 | 3 |
0.018 | 179358 | 3 |
0.019 | 1037647 | 5 |
0.020 | 1523093 | 7 |
0.021 | 282857 | 2 |
Last trade - 09.30am 30/08/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
Day chart unavailable